About PierianDx
PierianDx is a company based in Saint Louis (United States) founded in 2014 by Rakesh Nagarajan was acquired by Velsera in January 2023.. PierianDx has raised $69.35 million across 7 funding rounds from investors including Inova, RTI International and Orbimed. The company has 234 employees as of April 05, 2024. PierianDx has completed 1 acquisition, including Tute Genomics. PierianDx offers products and services including Clinical Genomics Workspace, Genomics Knowledgebase, Professional Services, and IVD Partnerships. PierianDx operates in a competitive market with competitors including ArcherDX, Personalis, Variantyx, ImaginAb and OncoDNA, among others.
- Headquarter Saint Louis, United States
- Employees 234 as on 05 Apr, 2024
- Founders Rakesh Nagarajan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pieriandx India Private Limited
- Date of Incorporation 07 Jan, 2016
- Jurisdiction Pune City, Maharashtra, India
-
Annual Revenue
$6.23 M (USD)50.92as on Mar 31, 2023
-
Net Profit
$469.89 K (USD)60.43as on Mar 31, 2023
-
EBITDA
$921.69 K (USD)57.12as on Mar 31, 2023
-
Total Equity Funding
$69.35 M (USD)
in 7 rounds
-
Latest Funding Round
$30 M (USD), Series C
Nov 02, 2021
-
Investors
Inova
& 8 more
-
Employee Count
234
as on Apr 05, 2024
- Investments & Acquisitions
-
Acquired by
Velsera
(Jan 13, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PierianDx
PierianDx offers a comprehensive portfolio of products and services, including Clinical Genomics Workspace, Genomics Knowledgebase, Professional Services, and IVD Partnerships. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for analyzing and interpreting genomic data in clinical settings.
Curated resource for accurate variant interpretations and treatment options.
Support for genomics workflows and assay validation processes.
Services for integrating genomic reporting in IVD assays.
Unlock access to complete
Funding Insights of PierianDx
PierianDx has successfully raised a total of $69.35M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $30.0M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series C - PierianDx | Valuation | Orbimed | |
| Nov, 2021 | Amount | Debt – Conventional - PierianDx | Valuation |
investors |
|
| Oct, 2019 | Amount | Series B - PierianDx | Valuation | ATW Partners , SJF Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PierianDx
PierianDx has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Inova, RTI International and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Growth-stage US tech companies are funded by Health Catalyst Capital.
|
Founded Year | Domain | Location | |
|
ATW Partners is engaged in smart and strategic investing.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PierianDx
PierianDx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Tute Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cloud-based genome analysis for precision medicine is provided.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - PierianDx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pieriandx Comparisons
Competitors of PierianDx
PierianDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ArcherDX, Personalis, Variantyx, ImaginAb and OncoDNA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| domain | founded_year | HQ Location |
Genomics data analysis platform for healthcare diagnostics is offered.
|
|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Genomic and theranostic services for oncology precision medicine are delivered.
|
|
| domain | founded_year | HQ Location |
Provider of test panels for personalized cancer therapies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pieriandx
Frequently Asked Questions about PierianDx
When was PierianDx founded?
PierianDx was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is PierianDx located?
PierianDx is headquartered in Saint Louis, United States. It is registered at Saint Louis, Missouri, United States.
Is PierianDx a funded company?
PierianDx is a funded company, having raised a total of $69.35M across 7 funding rounds to date. The company's 1st funding round was a Series B of $27M, raised on Jun 01, 2015.
How many employees does PierianDx have?
As of Apr 05, 2024, the latest employee count at PierianDx is 234.
What is the annual revenue of PierianDx?
Annual revenue of PierianDx is $6.23M as on Mar 31, 2023.
What does PierianDx do?
PierianDx was founded in 2014 in Saint Louis, United States, within the genetic testing sector. Patient-specific diagnoses and treatments for multiple diseases are delivered based on individual DNA analysis. Operations are supported by a proprietary cloud-based Clinical Genomicist Workstation software, which manages next-generation sequencing across six phases: case accessioning, sequencing, analysis, draft report, final report, and electronic health record integration.
Who are the top competitors of PierianDx?
PierianDx's top competitors include Personalis, ImaginAb and OncoDNA.
What products or services does PierianDx offer?
PierianDx offers Clinical Genomics Workspace, Genomics Knowledgebase, Professional Services, and IVD Partnerships.
How many acquisitions has PierianDx made?
PierianDx has made 1 acquisition, including Tute Genomics.
Who are PierianDx's investors?
PierianDx has 9 investors. Key investors include Inova, RTI International, Orbimed, ARUP Laboratories, and Velsera.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.